Capital Change Notice

Notice of issue of ordinary shares under Oceania’s long term incentive scheme.

This notice is given under NZX Listing Rules 3.13.1 and 3.15.2 and relates to the vesting of performance share rights granted under Oceania’s long term incentive scheme (LTI Scheme) 2021 Grant, pursuant to which selected key executives were issued performance share rights which entitle them to receive fully paid ordinary shares in Oceania should certain performance hurdles and vesting criteria be met (Share Rights).

Please see Appendix A for the remaining tranche of Share Rights on issue under the LTI Scheme.

Section 1: Issuer information
Name of issuer Oceania Healthcare Limited
NZX ticker code OCA
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZOCAE0002SO
Currency NZD

Section 2: Capital change details
Number issued 19,063
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $Nil
Nature of the payment (for example, cash or other consideration) N/A
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products issued (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence) 0.0026%

For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date) Certain of the Share Rights issued under the 2021 Grant pursuant to the LTI Scheme have vested and been exercised and have converted into 19,063 Ordinary Shares.

Each Share Right entitled the holder to receive one Ordinary Share in OCA on vesting and exercise, subject to adjustment for satisfaction of tax obligations of the participants. The exercise price was nil.

The remaining Share Rights under the LTI Scheme 2021 Grant have lapsed and been cancelled.

Reason for issue and specific authority for issue (the reason for change must be identified here) Issue of ordinary shares under the LTI Scheme 2021 Grant as a consequence of the vesting and exercise of Share Rights previously granted to retain and incentivise selected key executives.

Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. 724,231,030 ordinary shares after the issue.

353,685 total Share Rights on issue. Details of the tranche of Share Rights on issue are set out in Appendix A to this notice.
In the case of an acquisition of shares, whether those shares are to be held as treasury stock N/A

Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made Board resolutions dated 25 August 2021 and Listing Rule 4.6.1

Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements) Terms of the LTI Scheme. The issued shares rank equally with the other fully paid ordinary shares on issue.

Date of issue/acquisition/redemption 10/07/24

Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement
Claire Fisher
Contact person for this announcement Claire Fisher
Contact phone number 09 361 0350
Contact email address [email protected]
Date of release through MAP 11/07/24


 
APPENDIX A
SHARE RIGHTS ON ISSUE

Tranche Hurdle Number Commencement Date Measurement Date Vesting Date
2022TSR3 TSR 353,685 1 April 2022 31 March 2025 31 March 2025
Total: 353,685

---

Announcement PDF